185 related articles for article (PubMed ID: 38050320)
1. Hub biomarkers in ultrasound-guided bladder cancer and osteosarcoma: Myosin light chain kinase and caldesmon.
Li H; Lin G; Cui M; Wang L; Ding D; Li X; Fan X; Yang Q; Wang Y; Kang C; Zhang L; Liu B; Su J
Medicine (Baltimore); 2023 Dec; 102(48):e36414. PubMed ID: 38050320
[TBL] [Abstract][Full Text] [Related]
2. MYLK and CALD1 as molecular targets in bladder cancer.
Jin H; Liu B; Guo X; Qiao X; Jiao W; Yang L; Song X; Wei Y; Jin T
Medicine (Baltimore); 2023 Nov; 102(47):e36302. PubMed ID: 38013282
[TBL] [Abstract][Full Text] [Related]
3. Identification of Hub Genes Associated with Progression and Prognosis of Bladder Cancer by Integrated Bioinformatics Analysis.
Jiang S; Ma J; Wei S; Ren P; Liu J; Zhou Y; Liu D; Zhang X
Arch Esp Urol; 2022 Nov; 75(9):779-790. PubMed ID: 36472061
[TBL] [Abstract][Full Text] [Related]
4. Role of PAX6, TRPA1, BCL11B, MCOLN2, CUX1, EMX1 in colorectal cancer and osteosarcoma.
Zhang J; Gao Q; Hou S; Chi X; Zheng M; Zhang Q; Shan H; Zhang X; Kang C
Medicine (Baltimore); 2024 Feb; 103(5):e37056. PubMed ID: 38306561
[TBL] [Abstract][Full Text] [Related]
5. CCNB2 as a potential biomarker of bladder cancer via the high throughput technology.
Zhang L; Liu B; Su J
Medicine (Baltimore); 2023 Feb; 102(6):e32825. PubMed ID: 36820589
[TBL] [Abstract][Full Text] [Related]
6. CAV1 and KRT5 are potential targets for prostate cancer.
Guo L; Liu Y; Yang T; Wang G; Liu J; Li S; Liu B; Cai J
Medicine (Baltimore); 2023 Dec; 102(49):e36473. PubMed ID: 38065913
[TBL] [Abstract][Full Text] [Related]
7. CALD1, CNN1, and TAGLN identified as potential prognostic molecular markers of bladder cancer by bioinformatics analysis.
Liu Y; Wu X; Wang G; Hu S; Zhang Y; Zhao S
Medicine (Baltimore); 2019 Jan; 98(2):e13847. PubMed ID: 30633156
[TBL] [Abstract][Full Text] [Related]
8. RRP9 and DDX21 as new biomarkers of colorectal cancer.
Chi X; Yang N; Liu Y
Medicine (Baltimore); 2023 Oct; 102(43):e34384. PubMed ID: 37904456
[TBL] [Abstract][Full Text] [Related]
9. MYLK and MYL9 expression in non-small cell lung cancer identified by bioinformatics analysis of public expression data.
Tan X; Chen M
Tumour Biol; 2014 Dec; 35(12):12189-200. PubMed ID: 25179839
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential crucial genes and key pathways in osteosarcoma.
Liu J; Wu S; Xie X; Wang Z; Lei Q
Hereditas; 2020 Jul; 157(1):29. PubMed ID: 32665038
[TBL] [Abstract][Full Text] [Related]
11. MYC and NCAPG2 as molecular targets of colorectal cancer and gastric cancer in nursing.
Mi X; Shan H; Kang C; Zhang J; Hou S; Gao Y; Hao L; Gao X; Gao Q; Chi X; Zhang Q
Medicine (Baltimore); 2024 May; 103(18):e38029. PubMed ID: 38701261
[TBL] [Abstract][Full Text] [Related]
12. Investigating age‑induced differentially expressed genes and potential molecular mechanisms in osteosarcoma based on integrated bioinformatics analysis.
Wang JS; Duan MY; Zhong YS; Li XD; Du SX; Xie P; Zheng GZ; Han JM
Mol Med Rep; 2019 Apr; 19(4):2729-2739. PubMed ID: 30720085
[TBL] [Abstract][Full Text] [Related]
13. Identification of critical genes associated with human osteosarcoma metastasis based on integrated gene expression profiling.
Fan H; Lu S; Wang S; Zhang S
Mol Med Rep; 2019 Aug; 20(2):915-930. PubMed ID: 31173206
[TBL] [Abstract][Full Text] [Related]
14. Role of TOP2A and CDC6 in liver cancer.
Jia W; Liu X; Zhang Z
Medicine (Baltimore); 2023 Oct; 102(42):e35604. PubMed ID: 37861550
[TBL] [Abstract][Full Text] [Related]
15. KIF20A as a potential biomarker of renal and bladder cancers based on bioinformatics and experimental verification.
Wang H; Ma X; Li S; Su J; Fan B; Liu B; Ni X
Aging (Albany NY); 2023 May; 15(11):4714-4733. PubMed ID: 37310408
[TBL] [Abstract][Full Text] [Related]
16. Identification of CD20, ECM, and ITGA as Biomarkers for Osteosarcoma by Integrating Transcriptome Analysis.
Wang DW; Yu SY; Cao Y; Yang L; Liu W; Er XQ; Yao GJ; Bi ZG
Med Sci Monit; 2016 Jun; 22():2075-85. PubMed ID: 27314445
[TBL] [Abstract][Full Text] [Related]
17. CpG methylation patterns are associated with gene expression variation in osteosarcoma.
Wang Q
Mol Med Rep; 2017 Jul; 16(1):901-907. PubMed ID: 28560411
[TBL] [Abstract][Full Text] [Related]
18. CD3D and CD247 are the molecular targets of septic shock.
Yang Q; Feng Z; Ding D; Kang C
Medicine (Baltimore); 2023 Jul; 102(29):e34295. PubMed ID: 37478215
[TBL] [Abstract][Full Text] [Related]
19. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
20. Screening for metastatic osteosarcoma biomarkers with a DNA microarray.
Diao CY; Guo HB; Ouyang YR; Zhang HC; Liu LH; Bu J; Wang ZH; Xiao T
Asian Pac J Cancer Prev; 2014; 15(4):1817-22. PubMed ID: 24641415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]